Michael N Neely MD MSc
Professor of Pediatrics, Clinical Scholar, University of Southern California
Join to view full profile
Laboratory of Applied Pharmacokinetics4650 Sunset Blvd, MS #176Los Angeles, CA 90027
Phone+1 323-361-2509
Dr. Neely is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern CaliforniaMD, Clinical and Biomedical Investigations, 2011- University Hospitals of ClevelandFellowship, 1999 - 2002
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1996 - 1999
University of California, Davis, School of MedicineClass of 1996- University of CaliforniaBA, Neurobiology, Highest Distinction Honors, 1991
Publications & Presentations
PubMed
- 1 citationsToward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing.Marc H Scheetz, Thomas P Lodise, Nathaniel J Rhodes, Manjunath P Pai, Erin F Barreto
Clinical Pharmacology and Therapeutics. 2026-09-01 - Predictive accuracy of population meropenem models in critically ill pneumonia patients.Adrian Valadez, Emma Harlan, Colin Jeantet, Marc H Scheetz, Michael N Neely
Antimicrobial Agents and Chemotherapy. 2026-08-05 - Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society o...Erin F Barreto, Erin K McCreary, Rekha Pai Mangalore, Sonya Tang Girdwood, Rebecca Arriola
Pharmacotherapy. 2026-08-01
Journal Articles
- Maximal Concentration of Intravenous Busulfan as a Determinant of Veno-Occlusive Disease: A Pharmacokinetic-Pharmacodynamic Analysis in 293 Hematopoietic Stem Cell Tra...Michael Neely, MD, Nature
- Neurodevelopment and in utero antiretroviral exposure of HIV-‐exposed uninfected infants.Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM, Pediatrics;125(2):e250-?60
- Comment: Assessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients.Goutelle S, Neely MN, Bleyzac N, Ann Pharmacother;45(9):1171-?2
Books/Book Chapters
Abstracts/Posters
- Plasma and Intracellular Lopinavir (LPV) Pharmacokinetics/Pharmacodynamics (PK/PD).Neely MN, Van Guilder M, Saux M, Jelliffe R, Pellegrin J, Pellegrin I, Fleury H, Breilh D, 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Atazanavir concentrations in plasma, breast milk and vaginal secretions of HIV-‐infected women.Neely MN. Spencer L, Mordwinkin N, Leon T, Louie S, Jelliffe R, Kovacs A, 10th HIV Pharmacology Workshop, Amsterdam
- Intensive Pharmacokinetics of Zidovudine, Lamivudine, and Atazanavir and HIV-‐ 1 Viral Load in Breast Milk and Plasma in HIV+ Women Receiving HAART.Spencer L, Neely M, Mordwinkin N, Leon T, Fredericks T, Karim R, Louie S, Kovacs A, 16th Conference on Retroviruses and Opportunistic Infections (CROI)
Lectures
- Pediatric HIV Case Presentations.12th HIV Pharmacology Workshop, Miami
- Raltegravir.Maternal Child Adolescent Center, Los Angeles, CA
- Clinical Research: Ideas to Results.Grand Rounds, Department of Pediatrics, LAC+USC Medical Center
Other
- Pharmacokinetics and pharmacodynamics of once daily raltegravir and atazanavir in healthy volunteers. Master’s Thesis.Neely MN, University of Southern California
http://digitallibrary.usc.edu - How to complete an overseas elective.Neely MN, Resident Report
American Academy of Pediatrics - Amblyopia and vernier acuity.Neely MN, Senior honors thesis
U.C. Berkeley
Press Mentions
- Children’s Hospital Los Angeles Receives $2.8 Million Award to Use AI to Predict Precision Dosing for Critically Ill ChildrenDecember 20th, 2022
- Myocarditis and COVID-19 Vaccines: The Latest News for Parents and Why Three Children's Hospital Los Angeles Experts Say Vaccinating Your Child Is Still the Safest ChoiceApril 11th, 2022
- Children’s Hospital Los Angeles Awarded $2.4 Million to Study Treatment of Respiratory Infections in Children with TracheostomyAugust 23rd, 2021
Grant Support
- Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance SuppressionUNIVERSITY OF FLORIDA2023–2027
- Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance SuppressionUNIVERSITY OF FLORIDA2023–2027
- Precision Dosing for Critically Ill ChildrenCHILDREN'S HOSPITAL OF LOS ANGELES2022–2026
- Ontogeny Of Voriconazole Pharmaockinetics And MetabolismEunice Kennedy Shriver National Institute Of Child Health &Human Development2012
- Plasma And Genital HIV Dynamics In WomenNational Institute Of Allergy And Infectious Diseases2007–2010
External Links
- Laboratory of Applied Pharmacokineticshttp://www.lapk.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: